Boston Scientific Warned by FDA on Plants (AP)


AP - Boston Scientific Corp. shares dropped on Friday after federal regulators said they discovered problems in the medical device maker's quality control, a rare finding that could block new product approvals and jack up the price of the company's pending $27 billion Guidant Corp. deal.